Mdm2 association with p53 targets its ubiquitination

被引:204
作者
Fuchs, SY [1 ]
Adler, V [1 ]
Buschmann, T [1 ]
Wu, XW [1 ]
Ronai, Z [1 ]
机构
[1] CUNY Mt Sinai Sch Med, Ruttenberg Canc Ctr, New York, NY 10029 USA
关键词
p53; ubiquitination; Mdm2; stability;
D O I
10.1038/sj.onc.1202200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Key to p53 ability to mediate its multiple cellular functions lies in its stability, In the present study we have elucidated the mechanism by which Mdm2 regulates p53 degradation. Using in vitro and in vivo ubiquitination assays we demonstrate that Mdm2 association with p53 targets p53 ubiquitination, Exposure of cells to UV-irradiation inhibits this targeting. Mdm2 which is deficient in p53 binding failed to target p53 ubiquitination, suggesting that the association is essential for Mdm2 targeting ability. While mdm2-p53 complex is found in non-stressed cells, the amount of p53-bound mdm2 is decreased after UV-irradiation, further pointing to the relationship between mdm2 binding and p53 level. Similar to Swiss 3T3 cells, the dissociation of mdm2-p53 complex was also found in UV-treated Scid cells, lacking functional DNA-PK, suggesting that DNA-PK is not sufficient for dissociating mdm2 from p53, Together our studies point to the role of Mdm2, as one of p53-associated proteins, in targeting p53 ubiquitination.
引用
收藏
页码:2543 / 2547
页数:5
相关论文
共 42 条
[1]   Conformation-dependent phosphorylation of p53 [J].
Adler, V ;
Pincus, MR ;
Minamoto, T ;
Fuchs, SY ;
Bluth, MJ ;
BrandtRauf, PW ;
Friedman, FK ;
Robinson, RC ;
Chen, JM ;
Wang, XW ;
Harris, CC ;
Ronai, Z .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (05) :1686-1691
[2]   CHARACTERIZATION OF THE TUMOR SUPPRESSOR PROTEIN-P53 AS A PROTEIN-KINASE-C SUBSTRATE AND A S100B-BINDING PROTEIN [J].
BAUDIER, J ;
DELPHIN, C ;
GRUNWALD, D ;
KHOCHBIN, S ;
LAWRENCE, JJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (23) :11627-11631
[3]   HUMAN P53 IS PHOSPHORYLATED BY P60-CDC2 AND CYCLIN-B-CDC2 [J].
BISCHOFF, JR ;
FRIEDMAN, PN ;
MARSHAK, DR ;
PRIVES, C ;
BEACH, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (12) :4766-4770
[4]  
BROWN JP, 1997, BIOCHIM BIOPHYS ACTA, V1332, P1
[5]  
Chang YC, 1998, CELL GROWTH DIFFER, V9, P79
[6]   INTERACTIONS BETWEEN P53 AND MDM2 IN A MAMMALIAN-CELL CYCLE CHECKPOINT PATHWAY [J].
CHEN, CY ;
OLINER, JD ;
ZHAN, QM ;
FORNACE, AJ ;
VOGELSTEIN, B ;
KASTAN, MB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (07) :2684-2688
[7]   THE UBIQUITIN-PROTEASOME PROTEOLYTIC PATHWAY [J].
CIECHANOVER, A .
CELL, 1994, 79 (01) :13-21
[8]  
CORDONCARDO C, 1994, CANCER RES, V54, P794
[9]   c-Jun NH2-terminal kinases target the ubiquitination of their associated transcription factors [J].
Fuchs, SY ;
Xie, B ;
Adler, V ;
Fried, VA ;
Davis, RJ ;
Ronai, Z .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (51) :32163-32168
[10]  
Fuchs SY, 1996, ONCOGENE, V13, P1531